BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18460736)

  • 1. Microarray-based expression of DNA repair genes does not correlate with growth inhibition of cancer cells by natural products derived from traditional Chinese medicine.
    Konkimalla VS; Wang G; Kaina B; Efferth T
    Cancer Genomics Proteomics; 2008; 5(2):79-84. PubMed ID: 18460736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapy.
    Kuete V; Efferth T
    J Ethnopharmacol; 2011 Sep; 137(1):752-66. PubMed ID: 21763411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray-based prediction of cytotoxicity of tumor cells to cantharidin.
    Efferth T
    Oncol Rep; 2005 Mar; 13(3):459-63. PubMed ID: 15706417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
    Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
    Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer.
    Moreno V; Gemignani F; Landi S; Gioia-Patricola L; Chabrier A; Blanco I; González S; Guino E; Capellà G; Canzian F
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2101-8. PubMed ID: 16609022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene signatures developed from patient tumor explants grown in nude mice to predict tumor response to 11 cytotoxic drugs.
    Fiebig HH; Schüler J; Bausch N; Hofmann M; Metz T; Korrat A
    Cancer Genomics Proteomics; 2007; 4(3):197-209. PubMed ID: 17878523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
    Wang G; Dombkowski A; Chuang L; Xu XX
    Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine.
    Mahringer A; Karamustafa S; Klotz D; Kahl S; Konkimalla VB; Wang Y; Wang J; Liu HY; Boechzelt H; Hao X; Bauer R; Fricker G; Efferth T
    Cancer Genomics Proteomics; 2010; 7(4):191-205. PubMed ID: 20656985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.
    Koeppel F; Poindessous V; Lazar V; Raymond E; Sarasin A; Larsen AK
    Clin Cancer Res; 2004 Aug; 10(16):5604-13. PubMed ID: 15328203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer natural product library from traditional chinese medicine.
    Konkimalla VB; Efferth T
    Comb Chem High Throughput Screen; 2008 Jan; 11(1):7-15. PubMed ID: 18220539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines.
    Efferth T; Sauerbrey A; Halatsch ME; Ross DD; Gebhart E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):56-67. PubMed ID: 12616342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
    Amundson SA; Myers TG; Scudiero D; Kitada S; Reed JC; Fornace AJ
    Cancer Res; 2000 Nov; 60(21):6101-10. PubMed ID: 11085534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
    Sertel S; Eichhorn T; Sieber S; Sauer A; Weiss J; Plinkert PK; Efferth T
    Chem Biol Interact; 2010 Apr; 185(1):42-52. PubMed ID: 20144594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide excision repair protein levels vis-à-vis anticancer drug resistance in 60 human tumor cell lines.
    Chen ZP; Malapetsa A; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Panasci LC
    Ai Zheng; 2002 Mar; 21(3):233-9. PubMed ID: 12451985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma.
    Fautrel A; Andrieux L; Musso O; Boudjema K; Guillouzo A; Langouët S
    J Hepatol; 2005 Aug; 43(2):288-93. PubMed ID: 15922480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins.
    Anfosso L; Efferth T; Albini A; Pfeffer U
    Pharmacogenomics J; 2006; 6(4):269-78. PubMed ID: 16432535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transporter genes in cisplatin resistance.
    Konkimalla VB; Kaina B; Efferth T
    In Vivo; 2008; 22(3):279-83. PubMed ID: 18610736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Oncology Forum: perspectives for the year 2000.
    DeVita VT; Bleickardt EW
    Cancer J; 2001; 7 Suppl 1():S2-13. PubMed ID: 11504281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.